Finance

Lists
4554:TYO
Fuji Pharma Co Ltd
1 780,00 JP¥
+1,83%
(+32,00) 1D
9 հոկ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4554...
Open
1 735 JP¥
High
1 786 JP¥
Low
1 735 JP¥
Mkt. cap
47,24 մլրդ
Avg. vol.
101,79 հզր
Volume
122,30 հզր
Dividend
2,56%
Quarterly dividend
11 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
14,96
52-wk high
2 559 JP¥
52-wk low
1 535 JP¥
EPS
119 JP¥
Shares outstanding
29,92 մլն
No. of employees
2 հզր
Open
1 735 JP¥
High
1 786 JP¥
Low
1 735 JP¥
Mkt. cap
47,24 մլրդ
Avg. vol.
101,79 հզր
Volume
122,30 հզր
Dividend
2,56%
Quarterly dividend
11 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
14,96
52-wk high
2 559 JP¥
52-wk low
1 535 JP¥
EPS
119 JP¥
Shares outstanding
29,92 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
About Fuji Pharma Co Ltd
CEO-
Employees1,76 հզր
Founded01 ապր, 1965 թ.
Headquarters-
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
14,72 մլրդ
15,90 մլրդ
13,82 մլրդ
15,67 մլրդ
Cost of goods sold
8,71 մլրդ
9,08 մլրդ
8,30 մլրդ
10,33 մլրդ
Cost of revenue
8,71 մլրդ
9,08 մլրդ
8,30 մլրդ
10,33 մլրդ
Research and development expenses
3,34 մլրդ
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-428,00 մլն
4,03 մլրդ
3,90 մլրդ
4,34 մլրդ
Operating expense
4,39 մլրդ
4,03 մլրդ
3,90 մլրդ
4,34 մլրդ
Total operating expenses
13,10 մլրդ
13,11 մլրդ
12,21 մլրդ
14,67 մլրդ
Operating income
1,62 մլրդ
2,79 մլրդ
1,61 մլրդ
995,00 մլն
Other non operating income
68,00 մլն
-47,00 մլն
139,00 մլն
222,00 մլն
EBT including unusual items
1,30 մլրդ
195,00 մլն
489,00 մլն
1,43 մլրդ
EBT excluding unusual items
1,63 մլրդ
2,65 մլրդ
1,68 մլրդ
1,22 մլրդ
Income tax expense
133,00 մլն
-129,00 մլն
100,00 մլն
320,00 մլն
Effective tax rate
10,21%
-66,15%
20,45%
22,42%
Other operating expenses
-
-
-
-
Net income
1,17 մլրդ
324,00 մլն
389,00 մլն
1,11 մլրդ
Net profit margin
7,95%
2,04%
2,81%
7,07%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,00 մլն
1,00 մլն
Interest expense
-100,00 մլն
-84,00 մլն
-105,00 մլն
-98,00 մլն
Net interest expenses
-100,00 մլն
-84,00 մլն
-104,00 մլն
-97,00 մլն
Depreciation and amortization charges
1,38 մլրդ
-
-
-
EBITDA
2,61 մլրդ
3,78 մլրդ
2,64 մլրդ
1,99 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps